ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Drug Roundup: New FDA-Approved Treatments in Rheumatology

Drug Roundup: New FDA-Approved Treatments in Rheumatology

  • (©DmitryKalinovsky/Shutterstock.com)
    (©DmitryKalinovsky/Shutterstock.com)
  • Samsung Bioepis news release: http://www.samsungbioepis.com/en/newsroom/detail/Samsung-Bioepis-SB2-US-FDA-Approval-FINAL.html FDA prescribing label for Renflexis: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761054lbl.pdf
  • Silvergate Pharmaceuticals news release: http://silvergatepharma.com/index.php/2017/04/26/xatmep/ FDA prescribing label: http://silvergatepharma.com/wp-content/uploads/2017/04/PI-4-26-17.pdf
  • Inspirion Delivery Sciences news release: https://prnmedia.prnewswire.com/news-releases/inspirion-delivery-sciences-receives-fda-approval-for-roxybond-oxycodone-hydrochloride-tablets-cii-the-first-and-only-immediate-release-opioid-analgesic-with-abuse-deterrent-label-claims-300445964.html
  • AbbVie news release: https://prnmedia.prnewswire.com/news-releases/us-fda-approves-addition-of-moderate-to-severe-fingernail-psoriasis-data-to-abbvies-humira-adalimumab-prescribing-information-300431631.html
  • Radius Health news release: http://investors.radiuspharm.com/releasedetail.cfm?ReleaseID=1023557 FDA prescribing label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208743lbl.pdf
  • Roche news release: http://www.roche.com/media/store/releases/med-cor-2017-03-29.htm. FDA prescribing label: https://www.gene.com/download/pdf/ocrevus_prescribing.pdf
  • "FDA approves new psoriasis drug." FDA news release. Feb. 15, 2017 (https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm541981.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery). FDA prescribing label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761032lbl.pdf
  • Halyard Health news release: http://www.prnewswire.com/news-releases/fda-clears-halyard-healths-coolief-for-the-management-of-osteoarthritis-knee-pain-300442628.html

From a biosimilar to Remicade (infliximab) to new treatments for juvenile arthritis, osteoporosis and fingernail psoriasis, the FDA has approved a number of new treatments for patients with musculoskeletal, rheumatology and other autoimmune-related conditions. In this slideshow, we offer a glance at the new treatments.

 

 

Add new comment

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.